Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515304451/en/Tivic-Reports-First-Quarter-2025-Financial-Results-and-Provides-Updates-on-Business-Transformation
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250514637661/en/Tivic-Health-Enters-GMP-Manufacturing-Validation-Agreement-with-Scorpius-BioManufacturing-in-Preparation-for-FDA-Submission
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513120979/en/Tivic-Expands-VNS-Intellectual-Property-Portfolio
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250509414474/en/Tivic-Health-to-Report-First-Quarter-2025-Financial-Results-on-May-15th-Via-Conference-Call-and-Webcast
22 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250422218401/en/Tivic-Health-Reports-White-House-Briefing-and-FDA-Meetings-Secured-Positive-Interest-in-Potential-Military-and-Defense-Applications-of-Its-Product-Candidates
15 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250415663561/en/Tivic-Health-Extends-its-Worldwide-License-of-TLR5-Agonist-Entolimod-to-Include-the-Treatment-of-Neutropenia
ABOUT THIS PAGE